Vanguard Total Stock Market ETF
Latest Vanguard Total Stock Market ETF News and Updates
DividendsVTI Versus VOO ETF: Tax Efficiency, Explained
What's the difference between VTI and VOO ETFs, and which one is more tax efficient? Keep reading for everything that investors need to know. Cryptocurrency & BlockchainDoes Vanguard Have Any Cryptocurrency ETFs?
Vanguard has a plethora of ETFs, but are any of them geared toward crypto? Here's everything investors need to know. Fund ManagersWhere Are Interest Rates Going? Ray Dalio Weighs In
Ray Dalio, and Marketplace Morning Report host David Brancaccio discussed the future of the economy and the next recession. Here’s what you need to know. Company & Industry OverviewsREER 101: An Introduction to Real Effective Exchange Rates
The International Monetary Fund defines REER as an average of the bilateral real exchange rates between a country and its trading partners, weighted by their respective trade shares. HealthcareREITs 101: Understanding this Investment Vehicle
In this series, we’ll get down to the brass tacks of investing in the REIT sector, the market’s current landscape, and the benefits you can expect from this type of investment. FinancialsWill the Fed Have to Use More Unconventional Measures?
Global monetary policy is unconventional. From an era of lowering interest rates to boost economic growth, central bankers are taking rates into negative territory. Fund ManagersLarry Fink Says Lower Rates Hampered Savings around the World
Various central banks in developed nations (EFA) have lowered their key interest rates close to the zero level to revive their economies. Company & Industry OverviewsVarian’s Halcyon Treatment System Sees Emerging Market Demand
Halcyon The Halcyon system, Varian Medical Systems’ (VAR) recently launched cancer treatment device, aims to simplify and enhance IMRT (image-guided volumetric intensity modulated radiotherapy). The device has received clearance by the FDA (US Food and Drug Administration). By next year, Varian expects to receive regulatory approvals for the device in China and Japan. For more information […] Company & Industry OverviewsHow Saudi Arabia’s Bond Sale Affects US Treasury Bonds
Saudi Arabia has also been involved in the sale of US Treasuries. The country is the 15th-largest holder of US Treasury bonds in the world. Macroeconomic AnalysisWhy the Japan Services PMI Improved in June 2017
The Japan Services PMI (EWJ) (DXJ) stood at 53.3 in June 2017 compared to 53.0 in May 2017. It met the market expectation of 53.2. Company & Industry OverviewsNike’s Target Markets: Everything You Need to Know
Nike (NKE) faces some challenges in its target markets. In the US, economic growth rates have tapered down, and the trade war could affect its China market. Company & Industry OverviewsWhat Else Could Drive Gilead’s Long-Term Growth?
In December 2017, Kite, a Gilead Sciences (GILD) company, presented long-term follow-up data from its pivotal ZUMA-1 trial of Yescarta.Financials The big 3 ETF providers in the US—iShares, SPDR, and Vanguard
In the U.S., Blackrock (BLK), State Street GA (STT), and Vanguard are the top three ETF providers. They have a 40.1%, 22.3%, and 20.7% market share, respectively. Macroeconomic AnalysisREITs 101: Understanding this Vehicle
By Michael Orzano, Director, Global Equity Indices Publicly traded property stocks, including real estate investment trusts (or REITs) and real estate operating companies (or REOCs), allow investors to gain exposure to real estate, which is generally an illiquid asset class, without sacrificing the liquidity benefits of listed equities. They also typically offer higher yields than […] Macroeconomic AnalysisWhy Diversification Is More than Just a Buzzword
Diversification is important because a diversified portfolio has higher risk-adjusted returns than a portfolio exposed to only one security. Company & Industry OverviewsA Brief Recap of the Abbott–Alere Deal Developments
Three months after announcing a $5.8 billion deal in which Abbott Laboratories (ABT) would buy Alere (ALR), Alere rejected Abbott’s $50 million offer to end the deal. On December 7, Abbott sued Alere to terminate the deal. Macroeconomic AnalysisHow You Can Win More By Losing Less
Most investors focus much of their time on picking assets that have the potential to win. However, limiting downside risk is just as important. Macroeconomic AnalysisThe Rise of Factory Automation in China
The rise of factory automation in China (GCH) has been rapid and unprecedented. China is the largest market for robots and automated parts. Macroeconomic AnalysisThe Aging World Means a Graying Workforce
We’re in a rapidly aging world. According to the United Nations World Population Prospects report, the median age of the world is estimated to grow from 29 years in 2010 to 36 years by 2050. Macroeconomic AnalysisWhy Treasury Inflation-Protected Securities May Offer Some Value
TIPS may offer some value as inflation breakeven seems modest. TIPS provide investors a hedge against inflation just like gold (GLD) and other commodities (DBC). Company & Industry OverviewsAbbVie Expects Peak Sales of $7 Billion for Imbruvica
AbbVie (ABBV) has projected Imbruvica’s annual revenues to be $5 billion by 2020. That would be driven by a rapid uptake in the first line chronic lymphocytic leukemia (or CLL) segment. HealthcareWhy China’s Iron Ore Demand Could Soon Weaken
As China consumes more than 70% of seaborne-traded iron ore, it’s imperative for iron ore investors to track the country’s demand and outlook. HealthcareWhat Does Mexico’s Manufacturing PMI Indicate?
According to a report by Markit Economics, Mexico’s (EWW) manufacturing activity showed a slightly weaker improvement in December as compared to November 2017. MaterialsThe Marijuana Ecosystem’s Potential Business Opportunities
Given that legislative approval is the strongest driving factor behind the boost in the marijuana industry, companies have rushed to capitalize on the wave. Company & Industry OverviewsAlign Technology’s Growth Prospects amid Increasing Competition
The Chinese market is Align Technology’s major growth driver. However, the company is starting to witness strong competition from startups focused on the clear aligners market. Company & Industry OverviewsPfizer Is Pursuing Oncology, Inflammation, and Immunology Research
On May 9, 2017, the US Food and Drug Administration (or FDA) approved Pfizer (PFE) and Merck’s Bavencio (avelumab) as a treatment option for patients suffering from locally advanced or metastatic urothelial carcinoma (or UC). HealthcareWhy Japan Services PMI Didn’t Meet Expectations in November
The Japan Services PMI fell in November 2017. It came in at 51.2 compared to 53.4 in October. It didn’t meet the market expectation of 52.0. Company & Industry OverviewsInside Abbott’s Neuromodulation Business Growth
Abbott’s Medical Devices segment has products for rhythm management, heart failure, electrophysiology, structural heart diseases, neuromodulation, and more. HealthcareWhy Japan’s Services PMI Improved Solidly in October 2017
Japan’s services PMI (EWJ) (DXJ) rose solidly in October 2017. It stood at 53.4 in October 2017 compared to 51.0 in September 2017. HealthcareIMF: Why US Economic Growth Could Slow
The International Monetary Fund (or IMF), in its “World Economic Outlook” (or WEO) released in October, upgraded the economic forecast for the United Statess for 2017. Earnings ReportHow Mako Robots Are Driving Stryker’s Sales in 2017
Mako sales in 3Q17 In 3Q17, Stryker sold 33 Mako robots, compared with 30 robots in 3Q16. In 2Q17, Stryker installed 26 Mako robots. Of these 33 robots, 23 were installed in the United States. Around 40% of US sales are expected to be in competitive accounts. Stryker is training surgeons on its total knee application […] HealthcareA Look at Indonesia’s Manufacturing PMI in September 2017
Indonesia’s (IDX) (ASEA) manufacturing activity stood at 50.4 in September 2017 compared to 50.7 in August 2017. Company & Industry OverviewsThis Could Be Eli Lilly’s Long-Term Growth Driver
In September 2017, Eli Lilly announced that a 12-month open-label study showed a positive safety and tolerability profile of Galcanezumab for migraines. HealthcareWhy Japan’s Services PMI Has Been Falling Gradually
According to the report provided by Markit Economics, Japan’s services PMI (EWJ) (DXJ) stood at 51.0 in September 2017 compared to 51.6 in August 2017. Company & Industry OverviewsAmgen’s Pipeline Could Boost Its Long-Term Growth Opportunities
EVENITY (romosozumab) is a monoclonal antibody under investigation that acts by inhibiting the activity of sclerostin. HealthcareInsight into Japan’s Manufacturing in September 2017
Japan’s manufacturing PMI stood at 52.90 in September 2017, compared to 52.20 in August 2017. The PMI figure beat the preliminary market estimation of 52.5. Company & Industry OverviewsAtrial Fibrillation Ablation Could Be a Short-Term Growth Driver for MDT
More than 33 million patients suffer from AF, the most common form of heart arrhythmia. About 30% of these patients respond to antiarrhythmic drugs (or AAD). HealthcareHow Japan’s Service Activity Trended in August 2017
According to the latest report by Markit Economics, the Japan Services PMI (EWJ) (DXJ) stood at 51.6 in August 2017, compared with 52 in July 2017. HealthcareIndonesia Manufacturing PMI Saw Sharp Rise in August 2017
In August 2017, Indonesia’s (IDX) (ASEA) manufacturing activity saw a sharp rise in the overall business conditions as compared to a contraction in the previous month. HealthcareHow Japan’s Manufacturing Activity Trended in August 2017
Japan’s manufacturing PMI stood at 52.2 in August 2017 as compared to 52.1 in July 2017. Company & Industry OverviewsDivestiture of a Part of Medtronic’s PMR Business to Cardinal Health
Medtronics’ MITG (Minimally Invasive Therapies Group) business is expected to grow 3.5%–4.5%. HealthcareWhy the US Government Has Been Shut Down Before
A failure to raise the debt ceiling will likely result in a US government shutdown and a default by the US, which would be catastrophic for the global economy and financial markets (VTI) (USMV). HealthcareShould We Be Worried about Greenspan’s Bond Market Warning?
Greenspan cites rapid inflation growth as the reason for a bond market collapse. But the markets and Fed officials think otherwise.Macroeconomic Analysis What Japan’s Manufacturing Suggests for Its Economy
Japan’s manufacturing PMI (purchasing managers’ index) stood at 52.4 in June 2017 compared to 53.1 in May. Macroeconomic AnalysisWhat Japan’s Falling Retail Sales Indicate for the Economy
According to the data provided by Japan’s Ministry of Economy, Trade and Industry, Japan’s retail sales rose to 2% in May 2017 on a yearly basis. Macroeconomic AnalysisJapan’s Manufacturing PMI in May, and What to Make of It
The Japan Manufacturing PMI stood at 53.1 in May 2017, as compared to 52.7 in April, outperforming the preliminary market estimation of 52.0. Company & Industry OverviewsWhy Zoetis’s Apoquel and Cytopoint Are Expected to Report Robust Revenues
In 1Q17, Zoetis’s (ZTS) dermatology portfolio reported revenues of ~$57 million, driven by the steady adoption of Cytopoint and Apoquel. Macroeconomic AnalysisHow Would Higher Inflation Impact Small Caps?
Higher inflation rates suggest that the economy might be improving. It’s good for small caps. They tend to outperform large caps during economic upturns. Macroeconomic AnalysisWhy REITs Tend to Offer High Dividend Yield
COMPARING DIVIDEND YIELDS ACROSS ASSET CLASSES Since 1999, approximately half of the total return of the Dow Jones U.S. Select REIT Index has come from dividends. During periods of heightened volatility, this income could act as a buffer and may mitigate negative price movements. Historically, the Dow Jones U.S. Select REIT Index has produced higher […] Macroeconomic AnalysisGold Prices Recover amid Sell-Off
Demand for Gold Withstood Recent Selloff Despite the drop in the gold price in October, demand for gold bullion-backed exchange traded products (ETPs) held firm. Inflows have no doubt slowed down compared to earlier in the year (0.4% increase in holdings in October compared to 12% and 6% increases in February and June respectively), but […]